Project Grant R03HD114568

Award Date 7/22/24
Completion Date 6/30/26
Dollars Obligated $160K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $506,984 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the role of the LRP1 gene in the development of congenital heart disease (CHD). The primary objectives are to: Examine the deployment and migration of cardiac neural crest cells (CNCCs) and their dependence on LRP1 using in vitro and in vivo cell lineage fate mapping analysis. Investigate the cellular and molecular...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $605,275 to The Regents of the University of California, San Francisco (UCSF) to study the developmental mechanisms controlling left-right patterning of the interventricular septum (IVS) and how perturbations can lead to ventricular septal defects (VSDs). The project aims to elucidate the roles of the secreted guidance cues NTN1 and SLIT2 in...
This $161,500 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is intended to establish basic science-clinical collaborations to understand the molecular mechanisms of heterotaxy, a severe form of congenital heart disease that affects 3-4% of patients with congenital heart defects. The funding will support research at the University of Virginia to...
This Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) will provide $315,999 to the Research Institute at Nationwide Children's Hospital to conduct research aimed at uncovering the role of incomplete penetrance genes in congenital heart disease (CHD). The key products and services to be delivered include: Sourcing a large cohort of CHD families from multiple data sources to perform a genetic association study and pedigree...
This federal Project Grant award in the amount of $757,089 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research to identify novel genes and genetic variants associated with congenital diaphragmatic hernia (CDH) and validate their role in mouse models. The awardee, Jackson Laboratory, will use genome data from a large CDH patient cohort to prioritize candidate genes and variants for validation in...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $802,762 to The University of Texas Southwestern Medical Center to investigate the genetic mechanisms underlying congenital heart disease (CHD). The key objectives are to: 1) Define the transcription factors and gene regulatory networks controlling human cardiac development; 2) Identify and characterize genetic variants regulating cardiac gene programs; and 3)...
This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 (Child Health and Human Development Extramural Research) will provide $763,886 to The Children's Hospital of Philadelphia (CHOP) to conduct comprehensive research on the role of alternative RNA splicing and epithelial-mesenchymal transition (EMT) during craniofacial development. The key objectives are to: 1) Leverage next-generation sequencing...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 Cardiovascular Diseases Research, will provide $267,000 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) from August 1, 2025 to July 31, 2027. The goal of this project is to identify shared genetic mechanisms that disrupt both heart and brain development in individuals with congenital heart disease (CHD) and neurodevelopmental delays (NDD). The...
This $876,314 Project Grant from the National Institutes of Health's National Institute of Child Health and Human Development Extramural Research program (CFDA 93.865) funds research at the University of North Texas on Notch signaling pathways related to hypoplastic left heart syndrome. The University will investigate the role of Notch1 signaling in vascular development of the heart using genome-edited induced pluripotent stem cell-derived vascularized cardiac organoids. Researchers aim to...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD, CFDA 93.865 Child Health and Human Development Extramural Research program) provides $1,708,120.00 to Baylor College of Medicine to develop less invasive intervention strategies for in utero repair of spina bifida. The project aims to create a pro-regenerative environment within the amniotic cavity to activate cellular and molecular cascades that can reduce the severity of spina bifida...

This federal Project Grant award of $160,000.00 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research by Baylor College of Medicine to elucidate the morphogenetic and molecular mechanisms by which the genes RERE and SPEN contribute to the development of congenital heart defects associated with 1p36 deletion syndrome.

The research aims to determine how SPEN deficiency triggers morphogenetic changes in the developing atrioventricular (AV) canal that lead to ventricular septal defects, and to investigate the molecular mechanisms by which SPEN and RERE interact to regulate the expression of key cardiac developmental genes like GATA4, BMP6, and BMP7. The innovative mouse models developed through this grant will provide a platform to test potential therapeutic and preventative interventions not only for 1p36 deletion syndrome, but also for a broader population at risk of ventricular septal defects.

Generated 7/1/25, 3:08 AM